New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Upcoming SlideShare
Loading in...5
×
 

New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

on

  • 154 views

 

Statistics

Views

Total Views
154
Views on SlideShare
154
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery Document Transcript

  • 1. New Zealand Diabetes Care Devices Market Outlook to 2018-Glucose Monitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 91Price: Single User License – US$2500New Zealand Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and InsulinDeliverySummaryGlobalData’s new report, “New Zealand Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin Delivery” provides key market data on the New Zealand Diabetes CareDevices market. The report provides value (USD million), volume (units) and average price (USD)data for each segment and sub-segment within two market categories – Glucose Monitoring andInsulin Delivery. The report also provides company shares and distribution shares data for each ofthe aforementioned market categories. The report is supplemented with global corporate-levelprofiles of the key market participants with information on company financials and pipelineproducts, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the New Zealand DiabetesCare Devicesmarket.- Key players covered include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Bayer HealthCareAG, Novo Nordisk A/S, Arkray, Inc., Animas Corporation and others.
  • 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the New Zealand DiabetesCare Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197505-new-zealand-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 51.2 List of Figures 62 Introduction 82.1 What is This Report About? 83 Diabetes Care Devices In New Zealand 93.1 Diabetes Care Devices, Market Segmentation 93.2 Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018 103.3 Diabetes Care Devices Market, New Zealand, Revenue Mix ($m), 2011 113.4 Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2011 123.5 Diabetes Care Devices, New Zealand, Company Share (2010-2011) 194 Glucose Monitoring In New Zealand 214.1 Glucose Monitoring, Market Segmentation 214.2 Glucose Monitoring Market, New Zealand, Revenue Mix ($m), 2011 224.3 Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2011 234.4 Glucose Monitoring Overall Revenue, (2004-2018) 244.4.1 Blood Glucose Meters, Revenue (2004-2018) 284.5 Glucose Monitoring Overall Volume (2004-2018) 324.5.1 Blood Glucose Meters, Volume (2004-2018) 364.6 Glucose Monitoring Average Price (2004-2018) 404.7 Glucose Monitoring Distribution Share (2010-2011) 414.8 Glucose Monitoring, New Zealand, Company Share (2010-2011) 425 Insulin Delivery In New Zealand 445.1 Insulin Delivery, Market Segmentation 44
  • 3. 5.2 Insulin Delivery Market, New Zealand, Revenue Mix ($m), 2011 455.3 Insulin Delivery Market, New Zealand, Segment Contribution (%), 2011 465.4 Insulin Delivery Overall Revenue, (2004-2018) 475.4.1 Insulin Pens, Revenue (2004-2018) 515.4.2 Insulin Pumps, Revenue (2004-2018) 555.5 Insulin Delivery Overall Volume (2004-2018) 575.5.1 Insulin Pens, Volume (2004-2018) 615.5.2 Insulin Pumps, Volume (2004-2018) 655.6 Insulin Delivery Average Price (2004-2018) 675.7 Insulin Delivery Distribution Share (2010-2011) 685.8 Insulin Delivery, New Zealand, Company Share (2010-2011) 696 Overview of Key Companies in New Zealand Diabetes Care Devices Market 716.1 F. Hoffmann-La Roche Ltd. 716.1.1 Company Overview 716.1.2 Share in the New Zealand Diabetes Care Devices Market 716.2 Abbott Laboratories 726.2.1 Company Overview 726.2.2 Share in the New Zealand Diabetes Care Devices Market 736.3 Bayer HealthCare AG 746.3.1 Company Overview 746.3.2 Share in the New Zealand Diabetes Care Devices Market 746.4 Novo Nordisk A/S 756.4.1 Company Overview 756.4.2 Share in the New Zealand Diabetes Care Devices Market 756.5 ARKRAY, Inc. 766.5.1 Company Overview 766.5.2 Share in the New Zealand Diabetes Care Devices Market 766.6 Animas Corporation 776.6.1 Company Overview 776.6.2 Share in the New Zealand Diabetes Care Devices Market 776.7 Eli Lilly and Company 786.7.1 Company Overview 786.8 LifeScan, Inc. 786.8.1 Company Overview 786.9 Medtronic, Inc. 796.9.1 Company Overview 796.10 Becton, Dickinson and Company 796.10.1 Company Overview 796.11 Sanofi 806.11.1 Company Overview 806.12 Terumo Corporation 806.12.1 Company Overview 80
  • 4. 6.13 Apex Biotechnology Corp. 816.13.1 Company Overview 816.14 Nipro Corporation 816.14.1 Company Overview 817 Diabetes Care Devices Market Pipeline Products 828 Appendix 858.1 Definitions of Markets Covered in the Report 868.1.1 Diabetes Care Devices 868.2 Research Methodology 888.3 Secondary Research 888.4 Primary Research 898.5 Models 898.6 Forecasts 908.7 Expert Panels 908.8 GlobalData Consulting 908.9 Currency Conversion 908.10 Contact Us 908.11 Disclaimer 911.1 List of TablesTable 1: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-201810Table 2: Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2011 12Table 3: Diabetes Care Devices, New Zealand, Cross-Segment Analysis, 2004-2018 14Table 4: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, Historic,2004-2011 16Table 5: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, Forecast,2011-2018 18Table 6: Diabetes Care Devices, New Zealand, Company Share by Revenue ($m), USD Constant,2010-2011 20Table 7: Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2011 23Table 8: Glucose Monitoring, New Zealand, Revenue ($m*) USD Constant, by Segment, Historic,2004-2011 25Table 9: Glucose Monitoring, New Zealand, Revenue ($m*) USD Constant, by Segment, Forecast,2011-2018 27Table 10: Blood Glucose Meters, New Zealand, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 29Table 11: Blood Glucose Meters, New Zealand, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 31Table 12: Glucose Monitoring, New Zealand, Volume (Units) by Segment, Historic, 2004-2011 33Table 13: Glucose Monitoring, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018 35Table 14: Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-
  • 5. 2011 37Table 15: Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018 39Table 16: Glucose Monitoring, New Zealand, Average Price ($), Historic, 2004-2011 40Table 17: Glucose Monitoring, New Zealand, Average Price ($), Forecast, 2011-2018 40Table 18: Glucose Monitoring, New Zealand, Distribution Share by Revenue ($m), USD Constant,2010-2011 41Table 19: Glucose Monitoring, New Zealand, Company Share by Revenue ($m), USD Constant,2010-2011 43Table 20: Insulin Delivery Market, New Zealand, Segment Contribution (%), 2011 46Table 21: Insulin Delivery, New Zealand, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 48Table 22: Insulin Delivery, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 50Table 23: Insulin Pens, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 52Table 24: Insulin Pens, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 54Table 25: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Revenue ($m) USD Constant,Historic, 2004-2011 55Table 26: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Revenue ($m) USD Constant,Forecast, 2011-2018 56Table 27: Insulin Delivery, New Zealand, Volume (Units) by Segment, Historic, 2004-2011 58Table 28: Insulin Delivery, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018 60Table 29: Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011 62Table 30: Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018 64Table 31: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Volume (Units), Historic, 2004-2011 65Table 32: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Volume (Units), Forecast,2011-2018 66Table 33: Insulin Delivery, New Zealand, Average Price ($), Historic, 2004-2011 67Table 34: Insulin Delivery, New Zealand, Average Price ($), Forecast, 2011-2018 67Table 35: Insulin Delivery, New Zealand, Distribution Share by Revenue ($m), USD Constant,2010-2011 68Table 36: Insulin Delivery, New Zealand, Company Share by Revenue ($m), USD Constant, 2010-2011 70Table 37: Diabetes Care Devices Market Pipeline Products 821.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 9Figure 2: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, 2004-201810
  • 6. Figure 3: Diabetes Care Devices Market, New Zealand, Revenue Mix ($m), 2011 11Figure 4: Diabetes Care Devices Market, New Zealand, Category Contribution (%), 2011 12Figure 5: Diabetes Care Devices, New Zealand, Cross-Segment Analysis, 2004-2018 13Figure 6: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, Historic,2004-2011 15Figure 7: Diabetes Care Devices, New Zealand, Overall Revenue ($m), USD Constant, Forecast,2011-2018 17Figure 8: Diabetes Care Devices, New Zealand, Company Share (%), 2011 19Figure 9: Glucose Monitoring, Market Segmentation 21Figure 10: Glucose Monitoring Market, New Zealand, Revenue Mix ($m), 2011 22Figure 11: Glucose Monitoring Market, New Zealand, Segment Contribution (%), 2011 23Figure 12: Glucose Monitoring, New Zealand, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 24Figure 13: Glucose Monitoring, New Zealand, Revenue ($m*) USD Constant, by Segment,Forecast, 2011-2018 26Figure 14: Blood Glucose Meters, New Zealand, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 28Figure 15: Blood Glucose Meters, New Zealand, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 30Figure 16: Glucose Monitoring, New Zealand, Volume (Units) by Segment, Historic, 2004-2011 32Figure 17: Glucose Monitoring, New Zealand, Volume (Units) by Segment, Forecast, 2011-201834Figure 18: Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011 36Figure 19: Blood Glucose Meters, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018 38Figure 20: Glucose Monitoring, New Zealand, Company Share (%), 2011 42Figure 21: Insulin Delivery, Market Segmentation 44Figure 22: Insulin Delivery Market, New Zealand, Revenue Mix ($m), 2011 45Figure 23: Insulin Delivery Market, New Zealand, Segment Contribution (%), 2011 46Figure 24: Insulin Delivery, New Zealand, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 47Figure 25: Insulin Delivery, New Zealand, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 49Figure 26: Insulin Pens, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 51Figure 27: Insulin Pens, New Zealand, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 53Figure 28: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Revenue ($m) USD Constant,Historic, 2004-2011 55Figure 29 Insulin Pumps(Traditional Insulin Pumps), New Zealand, Revenue ($m) USD Constant,Forecast, 2011-2018 56
  • 7. Figure 30: Insulin Delivery, New Zealand, Volume (Units) by Segment, Historic, 2004-2011 57Figure 31: Insulin Delivery, New Zealand, Volume (Units) by Segment, Forecast, 2011-2018 59Figure 32: Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Historic, 2004-2011 61Figure 33: Insulin Pens, New Zealand, Volume (Units) by Sub-Segment, Forecast, 2011-2018 63Figure 34: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Volume (Units), Historic, 2004-2011 65Figure 35: Insulin Pumps(Traditional Insulin Pumps), New Zealand, Volume (Units), Forecast,2011-2018 66Figure 36: Insulin Delivery, New Zealand, Company Share (%), 2011 69Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),New Zealand Diabetes Care DevicesMarket, 2011 71Figure 38: Abbott Laboratories, Company Share (%),New Zealand Diabetes Care Devices Market,2011 73Figure 39: Bayer HealthCare AG, Company Share (%),New Zealand Diabetes Care DevicesMarket, 2011 74Figure 40: Novo Nordisk A/S, Company Share (%),New Zealand Diabetes Care Devices Market,2011 75Figure 41: ARKRAY, Inc., Company Share (%),New Zealand Diabetes Care Devices Market, 201176Figure 42: Animas Corporation, Company Share (%),New Zealand Diabetes Care Devices Market,2011 77Contact: sales@reportsandreports.com for more information.